Association of the matrix metalloproteinase-3 (-439C/G) promoter polymorphism with Kawasaki disease in Korean children

Heart and Vessels

Volumn 23, Issue 5, 2008, Pages 341-347

  Hong, Young Mi ^a   Jin, Hyun Seung ^b   Park, In Sook ^b   Hong, Soo Jong ^b  

^a Ewha Womans University School of Medicine   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

Kawasaki disease; Matrix metalloproteinase

Indexed keywords

CYTOSINE; GUANINE; STROMELYSIN;

ALLELE; ARTICLE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; CORONARY ARTERY ANEURYSM; ECHOCARDIOGRAPHY; ENZYME BLOOD LEVEL; ENZYME IMMUNOASSAY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PATHOPHYSIOLOGY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION;

CHILD, PRESCHOOL; DNA; FEMALE; GENOTYPE; HUMANS; IMMUNOENZYME TECHNIQUES; INCIDENCE; KOREA; MALE; MATRIX METALLOPROTEINASE 3; MUCOCUTANEOUS LYMPH NODE SYNDROME; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC;

EID: 53149154511     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00380-008-1041-1     Document Type: Article

References (25)

1. Matsuura K, Kobayashi J, Bando K, Niwaya K, Tagusari O, Nakajima H, Kitamura S (2006) Redo off-pump coronary bypass grafting with arterial grafts for Kawasaki disease. Heart Vessels 21:361-364
2. Takeshita S, Tokutomi T, Kawase H, Nakatani K, Tsujimoto H, Kawamura Y, Sekine I (2001) Elevated serum levels of matrix metalloproteinase-9 (MMP-9) in Kawasaki disease. Clin Exp Immunol 125:340-344
3. Johnson LL, Dyer R, Hupe DJ (1998) Matrix metalloproteinases. Curr Opin Chem Biol 2:466-471
4. Gruber BL, Sorbi D, French DL, Marchese MJ, Nuovo GJ, Kew RR, Arbeit LA (1996) Markedly elevated serum MMP-9 (gelatinase B) levels in rheumatoid arthritis: A potentially useful laboratory marker. Clin Immunol Immunopathol 78:161-171
5. Brown DL, Hibbs MS, Kearney M, Loushin C, Isner JM (1995) Identification of 92-kD gelatinase in human coronary atherosclerotic lesions. Association of active enzyme synthesis with unstable angina. Circulation 91:2125-2131
6. Yoon S, Tromp G, Vongpunsawad S, Ronkainen A, Juvonen T, Kuivaniemi H (1999) Genetic analysis of MMP-3, MMP-9, and PAI-1 in Finnish patients with abdominal aortic or intracranial aneurysms. Biochem Biophys Res Commun 265:563-568
7. Hovsepian DM, Ziporin SJ, Sakurai MK, Lee JK, Curci JA, Thompson RW (2000) Elevated plasma levels of matrix metalloproteinase-9 in patients with abdominal aortic aneurysms: A circulating marker of degenerative aneurysm disease. J Vasc Interv Radiol 11:1345-1352
8. McMillan WD, Pearce WH (1999) Increased plasma levels of metalloproteinase 9 are associated with abdominal aortic aneurysms. J Vasc Surg 29:122-129
9. Ye S (2000) Polymorphism in matrix metalloproteinase gene promoters: implication in regulation of gene expression and susceptibility of various diseases. Matrix Biol 19:623-629
10. Chua PK, Melish ME, Yu Q, Yanagihara R, Yamamoto KS, Nerurkar VR (2003) Elevated levels of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 during the acute phase of Kawasaki disease. Clin Diagn Lab Immunol 10:308-314
11. Senzaki H, Masutani S, Kobayashi J, Kobayashi T, Nakano H, Nagasaka H, Sasaki N, Asano H, Kyo S, Yokote Y (2001) Circulating matrix metalloproteinase and their inhibitors in patients with Kawasaki disease. Circulation 104:860-863
12. Gavin PJ, Crawford SE, Shulman ST, Garcia FL, Rowley AH (2003) Systemic arterial expression of matrix metalloproteinases 2 and 9 in acute Kawasaki disease. Arterioscler Thromb Vasc Biol 23:576-581
13. Cho AR, Hong YM (2004) Matrix metalloproteinase, tissue inhibitors and cytokines in patients with Kawasaki disease. Korean J Pediatr 47:656-664
14. Lamblin N, Bauters C, Hermant X, Lablanche JM, Helbecque N, Amouyel P (2002) Polymorphisms in promoter regions of MMP-2, MMP-3, MMP-9 and MMP-12 genes as determinants of aneurismal coronary artery disease. J Am Coll Cardiol 40:43-48
15. Ye S, Eriksson P, Hamsten A, Kurkinen M, Humphries SE, Henney AM (1996) Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression. Biol Chem 271:13055-13060
16. Park JA, Shin KS, Kim YW (2005) Polymorphism of matrix metalloproteinase-3 promoter gene as a risk factor for coronary artery lesions in Kawasaki disease. J Korean Med Sci 20:607-611
17. Japanese Kawasaki Disease Research Committee (1984) Diagnostic guidelines of Kawasaki disease, 4th edn. Japan Kawasaki Disease Research Committee, Tokyo
18. Ye S, Watts GF, Mandalia S, Humphries SE, Henney AM (1995) Preliminary report: Genetic variation in human stromelysin gene promoter is associated with progression of atherosclerosis. Br Heart J 73:209-215
19. Samnegard A, Silveira A, Lundman P, Boquist S, Odeberg J, Hulthe J, McPheat W, Tornvall P, Bergstrand L, Ericsson CG, Hamsten A, Eriksson P (2005) Serum matrix metalloproteinase-3 concentration is influenced by MMP-3-1612 5A/6A promoter genotype and associated with myocardial infarction. J Intern Med 258:411-419
20. Ye S, Eriksson P, Hamsten A, Kurkinen M, Humphries SE, Henney AM (1996) Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression. J Biol Chem 271:13055-13060
21. Humphries S, Bauters C, Meirhaeghe A, Luong L, Bertrand M, Amouyel P (2002) The 5A/6A polymorphism in the promoter of the stromelysin-1 (MMP-3) gene as a risk factor for restenosis. Eur Heart J 23:721-725
22. Biezeveld MH, van Mierlo G, Lutter R, Kuipers IM, Dekker T, Hack CE, Newburger JW, Kuijpers TW (2005) Sustained activation of neutrophils in the course of Kawasaki disease: An association with matrix metalloproteinases. Clin Exp Immunol 141: 183-188
23. Mori M, Imagawa T, Yasui K, Kanaya A, Yokota S (2000) Predictors of coronary artery lesions after intravenous gamma-globulin treatment in Kawasaki disease. J Pediatr 137:77-80
24. Matsuyama T (1999) Tissue inhibitor of metalloproteinases-1 and matrix metalloproteinase-3 in Japanese healthy children and in Kawasaki disease and their clinical usefulness in juvenile rheumatoid arthritis. Pediatr Int 41:239-245
25. Senzaki H (2006) The pathogenesis of coronary artery aneurysms in Kawasaki disease: Role of matrix metalloproteinases. Arch Dis Child 91:847-851